Company attributes
Other attributes
Atomic AI is a company that has created a research and development platform powered by artificial intelligence (AI) and is designed to help streamline the process of drug discovery. It was founded in 2021 and was named by CB Insights as one of the most promising AI startups of 2023.
Atomic AI developed ATOM-1, a large language model (LLM) platform that uses chemical mapping data and deep learning technology. The company describes the platform as a foundation model that can be used in research and development to predict the structure and function of ribonucleic acid (RNA) and expedite the development of RNA therapeutics. The model can be applied to different RNA modalities, such as small molecules, mRNA vaccines, siRNAs, and circular RNA.
The company has another product called PARSE, which is an acronym for proprietary AI-driven 3D RNA structure engine. It generates RNA structural datasets and is intended to be used as part of the pipeline for drug development.
